Eqis Capital Management, Inc. Cellectis S.A. Transaction History

Eqis Capital Management, Inc.

$1.21 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$3.45 - $8.77 $359,017 - $912,632	-104,063 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.01 - $12.84 $141,128 - $226,227	17,619 Added 20.38%	104,063 $845,000
Q3 2021 Nov 12, 2021	BUY	$11.94 - $16.09 $271,503 - $365,870	22,739 Added 35.69%	86,444 $1.09 Million
Q2 2021 Aug 12, 2021	SELL	$14.36 - $20.93 $569,115 - $829,497	-39,632 Reduced 38.35%	63,705 $986,000
Q1 2021 May 14, 2021	BUY	$18.19 - $33.25 $156,434 - $285,950	8,600 Added 9.08%	103,337 $2.09 Million
Q4 2020 Feb 11, 2021	SELL	$15.87 - $31.64 $103,393 - $206,134	-6,515 Reduced 6.43%	94,737 $2.56 Million
Q3 2020 Nov 10, 2020	BUY	$15.7 - $20.84 $911,337 - $1.21 Million	58,047 Added 134.35%	101,252 $1.87 Million
Q2 2020 Aug 10, 2020	SELL	$8.21 - $21.02 $42,847 - $109,703	-5,219 Reduced 10.78%	43,205 $769,000
Q1 2020 May 12, 2020	BUY	$7.81 - $18.82 $56,934 - $137,197	7,290 Added 17.72%	48,424 $829,000
Q4 2019 Jan 24, 2020	SELL	$9.73 - $19.31 $5,974 - $11,856	-614 Reduced 1.47%	41,134 $704,000
Q3 2019 Nov 05, 2019	SELL	$10.15 - $16.89 $5,257 - $8,749	-518 Reduced 1.23%	41,748 $434,000
Q2 2019 Jul 18, 2019	SELL	$14.6 - $20.6 $24,455 - $34,505	-1,675 Reduced 3.81%	42,266 $659,000
Q1 2019 Apr 18, 2019	BUY	$15.53 - $19.75 $132,703 - $168,763	8,545 Added 24.14%	43,941 $806,000
Q4 2018 Jan 25, 2019	SELL	$15.58 - $28.41 $5,343 - $9,744	-343 Reduced 0.96%	35,396 $589,000
Q3 2018 Oct 17, 2018	BUY	$25.99 - $30.6 $4,990 - $5,875	192 Added 0.54%	35,739 $1.04 Million
Q2 2018 Jul 27, 2018	BUY	$27.78 - $38.53 $172,597 - $239,386	6,213 Added 21.18%	35,547 $1.01 Million
Q1 2018 Apr 06, 2018	BUY	$27.78 - $35.19 $102,091 - $129,323	3,675 Added 14.32%	29,334 $924,000
Q4 2017 Jan 25, 2018	BUY	$23.33 - $35.01 $598,624 - $898,321	25,659	25,659 $748,000

Others Institutions Holding CLLS

# of Institutions

Shares Held

10.8M

Call Options Held

5.9K

Put Options Held

1.4K

Long Focus Capital Management, LLC San Juan, PR

4.62M
Shares

$7.2 Million
0.36% of portfolio
Capital International Investors Los Angeles, CA

1.85M
Shares

$2.88 Million
0.0% of portfolio
Credit Suisse Ag Zurich, V8

1.44M
Shares

$2.24 Million
0.0% of portfolio
Ubs Asset Management Americas Inc Chicago, IL

1.44M
Shares

$2.24 Million
0.0% of portfolio
Baillie Gifford & CO

694K
Shares

$1.08 Million
0.0% of portfolio

View Full List

About Cellectis S.A.

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $71M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

More about CLLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.

Account